EDGAR Filing Documents for 0001144204-17-041241

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001144204-17-041241

Filing Date

2017-08-08

Accepted

2017-08-08 16:35:15

Documents

Period of Report

2017-08-08

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	v472653_6k.htm	6-K	14057
2	EXHIBIT 10.1	v472653_ex10-1.htm	EX-10.1	19538
	Complete submission text file	0001144204-17-041241.txt		34794

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 171015298
SIC: 2834 Pharmaceutical Preparations